611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO, CA
Market cap: $7.2M (2/08/2026)
Price: $0.13
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia
Provides Business Update and Reports Third Quarter 2025 Financial Results
Reg. FD
Material disclosure
Provides Business Update and Reports Second Quarter 2025 Financial Results
Completes Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
News, Securities Holder Rights or Indentures, Material Contracts
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement
Correspondence
Submission Upload